Related Experiment Videos
Latanoprost and cholinergic agonists in combination
Carol B Toris1, Albert Alm, Carl B Camras
1Department of Ophthalmology, 985540 University of Nebraska Medical Center, Omaha, NE 68198-5540, USA.
Survey of Ophthalmology
|September 3, 2002
Summary
Latanoprost effectively lowers intraocular pressure (IOP) when combined with cholinergic agonists like pilocarpine. This combination enhances aqueous humor drainage, offering greater IOP reduction than either medication alone.
Area of Science:
- Ophthalmology
- Pharmacology
Background:
- Latanoprost, a prostaglandin F(2alpha) analog prodrug, effectively reduces intraocular pressure (IOP) via uveoscleral outflow.
- Cholinergic agonists were previously thought to potentially interfere with prostaglandin analog efficacy.
Purpose of the Study:
- To investigate the efficacy of combining latanoprost with cholinergic agonists (e.g., pilocarpine) for IOP reduction.
- To elucidate the mechanisms underlying the combined effects of latanoprost and pilocarpine on aqueous humor dynamics.
Main Methods:
- Review of published clinical studies on latanoprost and cholinergic agonist combinations.
- Assessment of aqueous humor dynamics in ocular hypertensive patients using latanoprost and pilocarpine alone and in combination.
Main Results:
- Latanoprost enhances uveoscleral outflow, while pilocarpine improves outflow facility.
- Pilocarpine does not inhibit the uveoscleral effect of latanoprost.
- Combination therapy resulted in significantly greater IOP reduction compared to monotherapy.
Conclusions:
- Combining latanoprost with cholinergic agonists is an effective strategy for managing elevated intraocular pressure.
- The additive IOP-lowering effect is due to distinct mechanisms of action for each drug class.